AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
3 SEHK Growth Companies With Up To 30% Insider Ownership
Generated by AI AgentAlpha Inspiration
Monday, Sep 30, 2024 7:11 pm ET1min read
In the dynamic Hong Kong stock market, investors are increasingly focusing on companies with high insider ownership as a sign of confidence and alignment with shareholder interests. This article explores three growth companies listed on the Stock Exchange of Hong Kong (SEHK) that exhibit significant insider ownership and have the potential for up to 30% earnings growth.
1. **BYD (SEHK:1211)**
BYD, a leading player in the automobiles and batteries sectors, has a market cap of HK$753.40 billion and an insider ownership of 30.1%. The company's strong financial performance is reflected in its recent unaudited sales of 373,083 units in August 2024, up from 274,386 units a year ago. BYD's strategic partnership with Uber to deploy electric vehicles globally further enhances its growth prospects.
2. **Newborn Town (SEHK:9911)**
Newborn Town, an investment holding company operating in the social networking business, has a market cap of HK$2.95 billion and an insider ownership of 35.3%. The company's revenue is forecast to grow at 12.6% per year, outpacing the Hong Kong market's 7.3%. Recent earnings for the half-year ended June 30, 2024, showed sales of CNY 2.27 billion and net income of CNY 224.68 million, both up from last year.
3. **Akeso (SEHK:9926)**
Akeso, a biopharmaceutical company, has a market cap of HK$50.22 billion and an insider ownership of 20.5%. The company is forecast to grow earnings by 54.67% annually and become profitable within three years. Despite recent shareholder dilution and a significant revenue drop, Akeso's innovative drug ivonescimab has shown superior efficacy in clinical trials, enhancing its growth prospects.
In conclusion, these three SEHK-listed companies – BYD, Newborn Town, and Akeso – demonstrate strong insider ownership and promising growth prospects. Their earnings growth forecasts, coupled with robust business models and strategic decision-making, make them attractive investment opportunities in the dynamic Hong Kong stock market.
1. **BYD (SEHK:1211)**
BYD, a leading player in the automobiles and batteries sectors, has a market cap of HK$753.40 billion and an insider ownership of 30.1%. The company's strong financial performance is reflected in its recent unaudited sales of 373,083 units in August 2024, up from 274,386 units a year ago. BYD's strategic partnership with Uber to deploy electric vehicles globally further enhances its growth prospects.
2. **Newborn Town (SEHK:9911)**
Newborn Town, an investment holding company operating in the social networking business, has a market cap of HK$2.95 billion and an insider ownership of 35.3%. The company's revenue is forecast to grow at 12.6% per year, outpacing the Hong Kong market's 7.3%. Recent earnings for the half-year ended June 30, 2024, showed sales of CNY 2.27 billion and net income of CNY 224.68 million, both up from last year.
3. **Akeso (SEHK:9926)**
Akeso, a biopharmaceutical company, has a market cap of HK$50.22 billion and an insider ownership of 20.5%. The company is forecast to grow earnings by 54.67% annually and become profitable within three years. Despite recent shareholder dilution and a significant revenue drop, Akeso's innovative drug ivonescimab has shown superior efficacy in clinical trials, enhancing its growth prospects.
In conclusion, these three SEHK-listed companies – BYD, Newborn Town, and Akeso – demonstrate strong insider ownership and promising growth prospects. Their earnings growth forecasts, coupled with robust business models and strategic decision-making, make them attractive investment opportunities in the dynamic Hong Kong stock market.
Alpha Inspiration
If I have seen further, it is by standing on the shoulders of giants.
Latest Articles
Coherent’s 18.32% Surge Extends Two-Day Rally to 23.78% as Technical Analysis Points to Bullish Momentum
Nov.06 2025
Sandisk's 11.27% Surge Driven by Bullish Candlestick Patterns, Golden Cross and MACD Crossover Signal Strong Uptrend
Nov.05 2025
Royalty Pharma Surges 8.36% on Bullish Engulfing Pattern and Golden Cross Momentum
Nov.05 2025
Lam Research Surges 127% on Golden Cross and Fibonacci Breakout as Bullish Signals Intensify
Nov.05 2025
Amgen Surges 7.95% on Bullish Engulfing and Golden Cross Momentum
Nov.05 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet